Atypical Antipsychotic Drugs Directly Impair Insulin Action in Adipocytes: Effects on Glucose Transport, Lipogenesis, and Antilipolysis
- 28 June 2006
- journal article
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 32 (4) , 765-772
Abstract
Treatment with second-generation antipsychotics (SGAs) has been associated with weight gain and the development of diabetes mellitus, although the mechanisms are unknown. We tested the hypothesis that SGAs exert direct cellular effects on insulin action and substrate metabolism in adipocytes. We utilized two cultured cell models including 3T3-L1 adipocytes and primary cultured rat adipocytes, and tested for effects of SGAs risperidone (RISP), clozapine (CLZ), olanzapine (OLZ), and quetiapine (QUE), together with conventional antipsychotic drugs butyrophenone (BUTY), and trifluoperazine (TFP), over a wide concentration range from 1 to 500 M. The effects of antipsychotic drugs on basal and insulin-stimulated rates of glucose transport were studied at 3 h, 15 h, and 3 days. Both CLZ and OLZ (but not RISP) at doses as low as 5 M were able to significantly decrease the maximal insulin-stimulated glucose transport rate by 40% in 3T3-L1 cells, whereas CLZ and RISP reduced insulin-stimulated glucose transport rates in primary cultured rat adipocytes by 50–70%. Conventional drugs (BUTY and TFP) did not affect glucose transport rates. Regarding intracellular glucose metabolism, both SGAs (OLZ, QUE, RISP) and conventional drugs (BUTY and TFP) increased basal and/or insulin-stimulated glucose oxidation rates, whereas rates of lipogenesis were increased by CLZ, OLZ, QUE, and BUTY. Finally, rates of lipolysis in response to isoproterenol were reduced by the SGAs (CLZ, OLZ, QUE, RISP), but not by BUTY or TFP. These experiments demonstrate that antipsychotic drugs can differentially affect insulin action and metabolism through direct cellular effects in adipocytes. However, only SGAs were able to impair the insulin-responsive glucose transport system and to impair lipolysis in adipocytes. Thus, SGAs directly induce insulin resistance and alter lipogenesis and lipolysis in favor of progressive lipid accumulation and adipocyte enlargement. These effects of SGAs on adipocytes could explain, in part, the association of SGAs with weight gain and diabetes.Keywords
This publication has 34 references indexed in Scilit:
- Atypical Antipsychotics and Glucose HomeostasisThe Journal of Clinical Psychiatry, 2005
- Atypical antipsychotic agents and increased risk of diabetes: class action or differential action?Expert Opinion on Drug Safety, 2005
- Atypical Antipsychotic Drug Use and DiabetesPsychotherapy and Psychosomatics, 2002
- Inhibition of glucose transport in PC12 cells by the atypical antipsychotic drugs risperidone and clozapine, and structural analogs of clozapineBrain Research, 2001
- Pharmacokinetics and tissue distribution of olanzapine in ratsBiopharmaceutics & Drug Disposition, 1999
- Distribution after repeated oral administration of different dose levels of risperidone and 9-hydroxy-risperidone in the brain and other tissues of ratPsychopharmacology, 1998
- Acute Clozapine Overdose: Plasma Concentration and OutcomePharmacopsychiatry, 1998
- Distribution of Fluphenazine and Its Metabolites in Brain Regions and Other Tissues of the RatNeuropsychopharmacology, 1995
- Tissue Concentrations of Clozapine and its Metabolites in the RatNeuropsychopharmacology, 1993
- A simple method to determine fat cell size and number in four mammalian speciesAmerican Journal of Physiology-Legacy Content, 1971